Huntington's disease, an autosomal dominant neurological disorder with onset in mid life, results in progressive involuntary choreiform movements and cognitive impairment which may be preceded or accompanied by emotional disturbance. ' Onset of symptoms usually occurs between 30 and 50 years of age but onset as early as 4 years and as late as 65 has been reported. 2 Death by suicide among individuals affected by Huntington' s disease is one of the serious consequences reported for this illness.3-7 In fact, in his now classic 1872 description, George Huntington included the tendency to suicide as one of the major features of the illness which bears his name.8 Although suicide is a leading cause of death in the United States, ranking ninth in 1976,9 suicide prediction remains problematic.'0 However, the recognition of factors associated with suicide in Huntington's disease patients may help in anticipating this risk. This paper presents data collected by the New England Huntington' The above comparisons with the general popula- Huntington' s disease patients may be overlooking undiagnosed persons with early signs as recognised by the family. '6-'8 It is striking that in our sample, the prevalence of suicide appears four times higher among suspected Huntington's disease patients than among those diagnosed. If many of the suspected cases were in the early stages of the illness, as seems likely, this implies that patients early in their disease are particularly prone to suicide. This possibility warrants further investigation with a larger group of patients and has clinical importance. If the diagnosis is made when subtle signs of HunSchoenfeld, Myers, Cupples, Berkman Sax, Clark tington' s disease are apparent, the affected individual is given the opportunity to discuss feelings about Huntington's disease, and the physician or genetic counsellor can then provide necessary psychological support.
An association between organic disease and suicidal potential has been suggested among patients with cancer,9 diabetes,20 renal failure2' and psychiatric disorders.22 Necropsies of suicide victims reveal them to be on the whole, a group with serious physical illnesses.23 Thus, the increased occurrence of suicide among patients with Huntington' s disease may not represent a disproportionate increase over patients with other disorders.
The proportional mortality rates calculated in this analysis do not express absolute risk of suicide for living Huntington's disease patients. The higher proportion of Huntington's disease patients dying of suicide is suggestive of a difference with the general population and further studies are needed to clarify these data. However, these preliminary data show that the relative risk of suicide occurrence among Huntington' s disease patients ranges from two to 23 times that of the general population. This higher proportion of deaths by suicide among Huntington's disease patients necessitates appropriate exploration of suicidal potential at the time of initial evaluation.
